In-Silico Pharmacology, Methods and Applications for Drug Design and Discovery: A Review

In biology, the terms “in vivo” and “in vitro” are more frequently used, while “in silico” denotes computer-based testing. The rapidly developing field of computational pharmacology, also known as in silico pharmacology or computational therapeutics, involves the development of software-based methods for collecting, analysing, and synthesizing biological and medical data from a wide range of sources. Software-based methods, database building, homology models and other molecular modelling, QSARs (quantitative structure–activity relationships), similarity searching, pharmacophores, machine learning, data mining, network analysis, and data analysis tools are all part of “in silico pharmacology.” Structure-based design is one of the earlier techniques in drug design. Medicinal targets are frequently important substances that are a component of a certain metabolic or signalling pathway that is thought to be linked to a certain disease state. In ligand-based methods, the information provided by discovered inhibitors for the target receptor is utilized.